{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:09:00Z","timestamp":1781629740602,"version":"3.54.5"},"reference-count":54,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1097\/hjh.0b013e3283567645","type":"journal-article","created":{"date-parts":[[2012,7,13]],"date-time":"2012-07-13T16:51:36Z","timestamp":1342198296000},"page":"1845-1855","source":"Crossref","is-referenced-by-count":27,"title":["Comparison of the effects of cilnidipine and amlodipine on cardiac remodeling and diastolic dysfunction in Dahl salt-sensitive rats"],"prefix":"10.1097","volume":"30","author":[{"given":"Miwa","family":"Takatsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamayo","family":"Murase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Ohtake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miki","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keigo","family":"Nashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chieko","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumi","family":"Niinuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shizuka","family":"Aritomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toyoaki","family":"Murohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohzo","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-23-20210208","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1291\/hypres.22.1","article-title":"Left ventricular hypertrophy in hypertension: stimuli, patterns, and consequences.","volume":"22","author":"Devereux","year":"1999","journal-title":"Hypertens Res"},{"key":"R2-23-20210208","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ejphar.2009.05.028","article-title":"Long-term administration of nifedipine attenuates cardiac remodeling and diastolic heart failure in hypertensive rats.","volume":"615","author":"Yamada","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"R3-23-20210208","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","article-title":"Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs. diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).","volume":"288","author":"Investigators","year":"2002","journal-title":"JAMA"},{"key":"R4-23-20210208","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0002-9343(03)00158-X","article-title":"A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension.","volume":"115","author":"Klingbeil","year":"2003","journal-title":"Am J Med"},{"key":"R5-23-20210208","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/S0022-3565(24)36515-2","article-title":"Effect of cilnidipine, a novel dihydropyridine Ca-channel antagonist, on N-type Ca channel in rat dorsal root ganglion neurons.","volume":"280","author":"Fujii","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"R6-23-20210208","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0014-2999(99)00237-X","article-title":"Selectivity of dihydropyridines for cardiac L-type and sympathetic N-type Ca2 channels.","volume":"373","author":"Uneyama","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"R7-23-20210208","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1291\/hypres.24.377","article-title":"Cilnidipine is as effective as benazepril for control of blood pressure and proteinuria in hypertensive patients with benign nephrosclerosis.","volume":"24","author":"Rose","year":"2001","journal-title":"Hypertens Res"},{"key":"R8-23-20210208","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1291\/hypres.27.379","article-title":"Comparison between cilnidipine and amlodipine besilate with respect to proteinuria in hypertensive patients with renal diseases.","volume":"27","author":"Kojima","year":"2004","journal-title":"Hypertens Res"},{"key":"R9-23-20210208","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1038\/sj.ki.5002623","article-title":"Antiproteinuric effect of the calcium channel blocker cilnidipine added to renin-angiotensin inhibition in hypertensive patients with chronic renal disease.","volume":"72","author":"Fujita","year":"2007","journal-title":"Kidney Int"},{"key":"R10-23-20210208","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/00004872-200202000-00023","article-title":"Cilnidipine improves spontaneously hypertensive rat coronary hemodynamics without altering cardiovascular mass and collagen.","volume":"20","author":"Varagic","year":"2002","journal-title":"J Hypertens"},{"key":"R11-23-20210208","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1097\/00004872-200205000-00035","article-title":"N- and L-type calcium channel antagonist improves glomerular dynamics, reverses severe nephrosclerosis, and inhibits apoptosis and proliferation in an l-NAMESHR model.","volume":"20","author":"Zhou","year":"2002","journal-title":"J Hypertens"},{"key":"R12-23-20210208","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000085713","article-title":"The N- and L-type calcium channel blocker cilnidipine suppresses renal injury in dahl rats fed a high-sucrose diet, an experimental model of metabolic syndrome.","volume":"101","author":"Konda","year":"2005","journal-title":"Nephron Physiol"},{"key":"R13-23-20210208","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1248\/bpb.29.933","article-title":"Effects of LN-type calcium channel antagonist, cilnidipine on progressive renal injuries in Dahl salt-sensitive rats.","volume":"29","author":"Konda","year":"2006","journal-title":"Biol Pharm Bull"},{"key":"R14-23-20210208","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000210396","article-title":"Different effects of LN-type and L-type calcium channel blockers on the renin-angiotensin-aldosterone system in SHRIzm.","volume":"30","author":"Konda","year":"2009","journal-title":"Am J Nephrol"},{"key":"R15-23-20210208","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1248\/bpb.27.1388","article-title":"Neuroprotective effects of a dual LN-type Ca(2) channel blocker cilnidipine in the rat focal brain ischemia model.","volume":"27","author":"Takahara","year":"2004","journal-title":"Biol Pharm Bull"},{"key":"R16-23-20210208","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.cardfail.2007.11.001","article-title":"Xanthine oxidase inhibition improves left ventricular dysfunction in dilated cardiomyopathic hamsters.","volume":"14","author":"Hayashi","year":"2008","journal-title":"J Card Fail"},{"key":"R17-23-20210208","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00395-003-0401-3","article-title":"Transthoracic echocardiography in rats. Evaluation of commonly used indices of left ventricular dimensions, contractile performance, and hypertrophy in a genetic model of hypertrophic heart failure (SHHF-Mcc-facp-Rats) in comparison with Wistar rats during aging.","volume":"98","author":"Reffelmann","year":"2003","journal-title":"Basic Res Cardiol"},{"key":"R18-23-20210208","first-page":"357","article-title":"New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function: a study in normals and dilated cardiomyopathy.","volume":"26","author":"Tei","year":"1995","journal-title":"J Cardiol"},{"key":"R19-23-20210208","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1097\/HJH.0b013e328302f0f7","article-title":"Pioglitazone attenuates cardiac hypertrophy in rats with salt-sensitive hypertension: role of activation of AMP-activated protein kinase and inhibition of Akt.","volume":"26","author":"Kato","year":"2008","journal-title":"J Hypertens"},{"key":"R20-23-20210208","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0735-1097(94)00369-2","article-title":"Differential effects of dobutamine and a phosphodiesterase inhibitor on early diastolic filling in patients with congestive heart failure.","volume":"25","author":"Nagata","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"R21-23-20210208","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1161\/01.HYP.0000026668.50222.1E","article-title":"AT1 receptor blockade reduces cardiac calcineurin activity in hypertensive rats.","volume":"40","author":"Nagata","year":"2002","journal-title":"Hypertension"},{"key":"R22-23-20210208","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00004872-200302000-00027","article-title":"Proximal tubular fluid angiotensin II levels in angiotensin II-induced hypertensive rats.","volume":"21","author":"Wang","year":"2003","journal-title":"J Hypertens"},{"key":"R23-23-20210208","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3317\/jraas.2006.013","article-title":"Genetic clamping of renin gene expression induces hypertension and elevation of intrarenal Ang II levels of graded severity in Cyp1a1-Ren2 transgenic rats.","volume":"7","author":"Mitchell","year":"2006","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"R24-23-20210208","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1161\/CIRCRESAHA.108.188995","article-title":"Acquisition of brain Na sensitivity contributes to salt-induced sympathoexcitation and cardiac dysfunction in mice with pressure overload.","volume":"104","author":"Ito","year":"2009","journal-title":"Circ Res"},{"key":"R25-23-20210208","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1161\/01.HYP.0000203772.78696.67","article-title":"Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and failure in low-aldosterone hypertensive rats.","volume":"47","author":"Nagata","year":"2006","journal-title":"Hypertension"},{"key":"R26-23-20210208","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1161\/01.HYP.0000153051.56460.6a","article-title":"NADPH oxidase inhibition attenuates oxidative stress but not hypertension produced by chronic ET-1.","volume":"45","author":"Elmarakby","year":"2005","journal-title":"Hypertension"},{"key":"R27-23-20210208","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1681\/ASN.2005040390","article-title":"Aldosterone stimulates reactive oxygen species production through activation of NADPH oxidase in rat mesangial cells.","volume":"16","author":"Miyata","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R28-23-20210208","doi-asserted-by":"crossref","first-page":"H2229","DOI":"10.1152\/ajpheart.00768.2003","article-title":"Infarction alters both the distribution and noradrenergic properties of cardiac sympathetic neurons.","volume":"286","author":"Li","year":"2004","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R29-23-20210208","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1161\/hc3101.093869","article-title":"Reduced myocardial sarcoplasmic reticulum Ca(2)-ATPase mRNA expression and biphasic force-frequency relations in patients with hypertrophic cardiomyopathy.","volume":"104","author":"Somura","year":"2001","journal-title":"Circulation"},{"key":"R30-23-20210208","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1161\/01.CIR.0000125741.88712.77","article-title":"Activation of matrix metalloproteinases precedes left ventricular remodeling in hypertensive heart failure rats: its inhibition as a primary effect of angiotensin-converting enzyme inhibitor.","volume":"109","author":"Sakata","year":"2004","journal-title":"Circulation"},{"key":"R31-23-20210208","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1161\/01.HYP.0000185189.46698.15","article-title":"Nicorandil promotes myocardial capillary and arteriolar growth in the failing heart of Dahl salt-sensitive hypertensive rats.","volume":"46","author":"Xu","year":"2005","journal-title":"Hypertension"},{"key":"R32-23-20210208","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/nm1119","article-title":"S-Glutathiolation by peroxynitrite activates SERCA during arterial relaxation by nitric oxide.","volume":"10","author":"Adachi","year":"2004","journal-title":"Nat Med"},{"key":"R33-23-20210208","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1097\/01.hjh.0000226200.73065.5d","article-title":"Contribution of reactive oxygen species to the pathogenesis of left ventricular failure in Dahl salt-sensitive hypertensive rats: effects of angiotensin II blockade.","volume":"24","author":"Guo","year":"2006","journal-title":"J Hypertens"},{"key":"R34-23-20210208","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1097\/HJH.0b013e328336ade3","article-title":"Cilnidipine suppresses podocyte injury and proteinuria in metabolic syndrome rats: possible involvement of N-type calcium channel in podocyte.","volume":"28","author":"Fan","year":"2010","journal-title":"J Hypertens"},{"key":"R35-23-20210208","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1471-4159.2009.06297.x","article-title":"Cilnidipine mediates a neuroprotective effect by scavenging free radicals and activating the phosphatidylinositol 3-kinase pathway.","volume":"111","author":"Lee","year":"2009","journal-title":"J Neurochem"},{"key":"R36-23-20210208","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1248\/yakushi.128.117","article-title":"Relationship between lipophilicities of 1,4-dihydropyridine derivatives and pharmacokinetic interaction strengths with grapefruit juice.","volume":"128","author":"Uesawa","year":"2008","journal-title":"Yakugaku Zasshi"},{"key":"R37-23-20210208","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/ki.2009.146","article-title":"Comparison of antioxidant activity of cilnidipine and amlodipine.","volume":"76","author":"Hishikawa","year":"2009","journal-title":"Kidney Int"},{"key":"R38-23-20210208","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.freeradbiomed.2004.09.036","article-title":"The expression of the NADPH oxidase subunit p22phox is regulated by a redox-sensitive pathway in endothelial cells.","volume":"38","author":"Djordjevic","year":"2005","journal-title":"Free Radic Biol Med"},{"key":"R39-23-20210208","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/path.1395","article-title":"The dynamic extracellular matrix: intervention strategies during heart failure and atherosclerosis.","volume":"200","author":"Heeneman","year":"2003","journal-title":"J Pathol"},{"key":"R40-23-20210208","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/S0735-1097(01)01548-0","article-title":"Long-term administration of amlodipine prevents decompensation to diastolic heart failure in hypertensive rats.","volume":"38","author":"Nishikawa","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"R41-23-20210208","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1161\/01.HYP.0000144400.49062.6b","article-title":"Angiotensin II regulation of collagen type I expression in cardiac fibroblasts: modulation by PPAR-gamma ligand pioglitazone.","volume":"44","author":"Chen","year":"2004","journal-title":"Hypertension"},{"key":"R42-23-20210208","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1161\/01.HYP.0000118584.33350.7d","article-title":"Hypertensive myocardial fibrosis and diastolic dysfunction: another model of inflammation H","volume":"43","author":"Kuwahara","year":"2004","journal-title":"ypertension"},{"key":"R43-23-20210208","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1161\/01.HYP.0000111831.50834.93","article-title":"Pressure-independent effects of angiotensin II on hypertensive myocardial fibrosis.","volume":"43","author":"Tokuda","year":"2004","journal-title":"Hypertension"},{"key":"R44-23-20210208","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1139\/y05-067","article-title":"Prophylactic effects of an N- and L-type Ca2 antagonist, cilnidipine, against cardiac hypertrophy and dysfunction in stroke-prone, spontaneously hypertensive rats.","volume":"83","author":"Takemori","year":"2005","journal-title":"Can J Physiol Pharmacol"},{"key":"R45-23-20210208","doi-asserted-by":"crossref","first-page":"R26","DOI":"10.1152\/ajpregu.00424.2007","article-title":"The role of local and systemic renin angiotensin system activation in a genetic model of sympathetic hyperactivity-induced heart failure in mice.","volume":"294","author":"Ferreira","year":"2008","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"R46-23-20210208","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1097\/HJH.0b013e32833d01dd","article-title":"A new-generation NL-type calcium channel blocker leads to less activation of the renin-angiotensin system compared with conventional L type calcium channel blocker.","volume":"28","author":"Konoshita","year":"2010","journal-title":"J Hypertens"},{"key":"R47-23-20210208","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1006\/bbrc.1995.1116","article-title":"Neurohumoral factors during transition from left ventricular hypertrophy to failure in Dahl salt-sensitive rats.","volume":"206","author":"Inoko","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"R48-23-20210208","first-page":"H930","article-title":"Beta-adrenoceptor downregulation in pacing-induced heart failure is associated with increased interstitial NE content.","volume":"266","author":"Delehanty","year":"1994","journal-title":"Am J Physiol"},{"key":"R49-23-20210208","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1172\/JCI112164","article-title":"Tracer norepinephrine kinetics in coronary circulation of patients with heart failure secondary to chronic pressure and volume overload.","volume":"76","author":"Rose","year":"1985","journal-title":"J Clin Invest"},{"key":"R50-23-20210208","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1161\/01.HYP.33.6.1447","article-title":"Effects of amlodipine and cilnidipine on cardiac sympathetic nervous system and neurohormonal status in essential hypertension.","volume":"33","author":"Sakata","year":"1999","journal-title":"Hypertension"},{"key":"R51-23-20210208","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1472-8206.2004.00236.x","article-title":"The evaluation of the N-type channel blocking properties of cilnidipine and other voltage-dependent calcium antagonists.","volume":"18","author":"Nap","year":"2004","journal-title":"Fundam Clin Pharmacol"},{"key":"R52-23-20210208","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1161\/01.RES.0000046452.67724.B8","article-title":"Gene expression in fibroblasts and fibrosis: involvement in cardiac hypertrophy.","volume":"91","author":"Manabe","year":"2002","journal-title":"Circ Res"},{"key":"R53-23-20210208","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1161\/01.HYP.0000022063.50739.60","article-title":"Norepinephrine and concentric hypertrophy in patients with end-stage renal disease.","volume":"40","author":"Zoccali","year":"2002","journal-title":"Hypertension"},{"key":"R54-23-20210208","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.jacc.2008.07.051","article-title":"Cardiorenal syndrome.","volume":"52","author":"Ronco","year":"2008","journal-title":"J Am Coll Cardiol"}],"container-title":["Journal of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/HJH.0b013e3283567645","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T00:49:45Z","timestamp":1743727785000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004872-201209000-00023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":54,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/hjh.0b013e3283567645","relation":{},"ISSN":["0263-6352"],"issn-type":[{"value":"0263-6352","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}